So JustSayin, which option do you think Oncosil took? the 90 day standard or the 45 day fast track? Are you that naive to even suggest that a company touting a product with billions of dollars of revenue and saving millions of lives is really going to choose the standard option? If you go to OSL's recent presentations/investor updates it clearly shows that they were intending to start recruiting for the global trial in 3Q2015 (between July and End of September)... CE marking submission was in July and given that you need the CE mark (for Oncosil's product) to start trials in the EU (and an IDE to start trials in the USA)... the only way the provided timetable was achievable was if the 45 day fast track option was paid up for... ie. A recommendation around end August/early September -> start recruiting September -> fulfill target to start trials 3Q2015. Or are you suggesting the company is making stuff up?
OSL Price at posting:
16.5¢ Sentiment: Sell Disclosure: Not Held
(20min delay)